Literature DB >> 21671922

Medically refractory epilepsy in autism.

Gemma Sansa1, Chad Carlson, Werner Doyle, Howard L Weiner, Judith Bluvstein, William Barr, Orrin Devinsky.   

Abstract

PURPOSE: Epilepsy and electroencephalographic abnormalities are frequent in idiopathic autism, but there is little information regarding treatment-resistant epilepsy (TRE) in this group. We sought to define the clinical and electrophysiologic characteristics and treatment outcomes in these patients.
METHODS: We retrospectively reviewed clinical and laboratory data of patients with idiopathic autism evaluated at NYU Epilepsy Center during a 20-year period. KEY
FINDINGS: One hundred twenty-seven patients had idiopathic autism and at least one epileptic seizure; 33.9% had TRE and 27.5% were seizure free. The remaining 38.6% of patients had infrequent seizures or insufficient data to categorize. Patients with TRE had a significantly earlier onset of seizures than seizure-free patients, and a trend for more developmental regression and motor and language delays. Three patients had surgical resection (two had limited improvement and one had no improvement) and one had an anterior callosotomy (no improvement). Vagus nerve stimulator (VNS) implantation provided limited improvement (2 patients) and no improvement (7). SIGNIFICANCE: This study found that TRE is common in idiopathic autism and more common with early age of seizure onset. Relatively few patients underwent surgical resection due to multifocal partial epilepsy, comorbid generalized epilepsy, or limited impact of ongoing partial seizures given other problems related to autism. Our small sample suggests that surgical and VNS outcomes in this group are less favorable than in other TRE populations. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21671922     DOI: 10.1111/j.1528-1167.2011.03069.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

1.  Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders.

Authors:  Krissy A R Doyle-Thomas; Dallas Card; Latha V Soorya; A Ting Wang; Jin Fan; Evdokia Anagnostou
Journal:  Res Autism Spectr Disord       Date:  2014-01

Review 2.  Evolution in the Understanding of Autism Spectrum Disorder: Historical Perspective.

Authors:  Mark Mintz
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

Review 3.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

Review 4.  Common neurological co-morbidities in autism spectrum disorders.

Authors:  Kiran P Maski; Shafali S Jeste; Sarah J Spence
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

5.  Single-neuron correlates of atypical face processing in autism.

Authors:  Ueli Rutishauser; Oana Tudusciuc; Shuo Wang; Adam N Mamelak; Ian B Ross; Ralph Adolphs
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

Review 6.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

7.  Epilepsy and electroencephalographic abnormalities in patients with diagnosis of idiopathic autism spectrum disorder in Medellín.

Authors:  Angélica Arteaga; Elizabeth Vélez; William Cornejo; Rodrigo Solarte; Angélica Lobo; Verónica Jaramillo; Julissa Otero
Journal:  Int J Psychol Res (Medellin)       Date:  2021 Jan-Jun

8.  Ketogenic diet improves core symptoms of autism in BTBR mice.

Authors:  David N Ruskin; Julia Svedova; Jessica L Cote; Ursula Sandau; Jong M Rho; Masahito Kawamura; Detlev Boison; Susan A Masino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

9.  Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literature.

Authors:  Ahmad Ghanizadeh; Michael Berk
Journal:  Iran J Child Neurol       Date:  2015

10.  Studying autism in rodent models: reconciling endophenotypes with comorbidities.

Authors:  Andrew Argyropoulos; Krista L Gilby; Elisa L Hill-Yardin
Journal:  Front Hum Neurosci       Date:  2013-07-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.